Growth Metrics

Dexcom (DXCM) Shareholder's Equity Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 30.46%
Dec 31, 2025 30.60%
Sep 30, 2025 37.75%
Jun 30, 2025 5.70%
Mar 31, 2025 0.88%
Dec 31, 2024 1.64%
Sep 30, 2024 -12.74%
Jun 30, 2024 15.90%
Mar 31, 2024 0.62%
Dec 31, 2023 -2.96%
Sep 30, 2023 24.30%
Jun 30, 2023 -6.89%
Mar 31, 2023 2.00%
Dec 31, 2022 4.39%
Sep 30, 2022 -4.58%
Jun 30, 2022 28.56%
Mar 31, 2022 33.10%
Dec 31, 2021 31.59%
Sep 30, 2021 27.53%
Jun 30, 2021 29.60%
Mar 31, 2021 76.01%
Dec 31, 2020 75.83%
Sep 30, 2020 96.17%
Jun 30, 2020 96.70%
Mar 31, 2020 39.77%
Dec 31, 2019 33.06%
Sep 30, 2019 35.95%
Jun 30, 2019 42.77%
Mar 31, 2019 58.55%
Dec 31, 2018 58.15%
Sep 30, 2018 46.41%
Jun 30, 2018 36.30%
Mar 31, 2018 51.80%
Dec 31, 2017 47.78%
Sep 30, 2017 46.68%
Jun 30, 2017 43.55%
Mar 31, 2017 20.16%
Dec 31, 2016 28.30%
Sep 30, 2016 35.44%
Jun 30, 2016 44.35%
Mar 31, 2016 55.59%
Dec 31, 2015 57.77%
Sep 30, 2015 68.09%
Jun 30, 2015 71.39%
Mar 31, 2015 65.11%
Dec 31, 2014 66.71%
Sep 30, 2014 53.95%
Jun 30, 2014 37.76%
Mar 31, 2014 22.28%
Dec 31, 2013 9.22%
Sep 30, 2013 -6.92%
Jun 30, 2013 -20.82%
Mar 31, 2013 -26.07%
Dec 31, 2012 -26.32%
Sep 30, 2012 -29.02%
Jun 30, 2012 -24.90%
Dec 31, 2011 71.31%